FMBTD
SRPT icon

First Midwest Bank Trust Division’s Sarepta Therapeutics SRPT Stock Holding History

First Midwest Bank Trust Division’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32,954
Closed -$628K – 471
2016
Q2 		$628K Buy
32,954
+8,754
+36% +$162K 0.08% 269
2016
Q1 		$472K Buy
24,200
+12,810
+112% +$224K 0.06% 257
2015
Q4 		$439K Sell
11,390
-2,551
-18% -$82.7K 0.07% 228
2015
Q3 		$448K Sell
13,941
-5,885
-30% -$200K 0.08% 227
2015
Q2 		$603K Buy
+19,826
New +$405K 0.1% 203

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

First Midwest Bank Trust Division's SRPT Position: Q3 2016 in Review

First Midwest Bank Trust Division sold out of Sarepta Therapeutics (SRPT) in Q3 2016, closing a stake of 32,954 shares — an estimated $628K sold.

First Midwest Bank Trust Division first reported a position in SRPT in Q2 2015 and held it in 5 quarters. The position peaked at $628K in Q2 2016. 186 funds tracked by Wall St. Rank hold SRPT as of Q3 2016.

  • First Midwest Bank Trust Division reported no remaining Sarepta Therapeutics position as of Q3 2016 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 32,954 Sarepta Therapeutics shares in Q3 2016, an estimated $628K.
  • First Midwest Bank Trust Division first reported a position in Sarepta Therapeutics in Q2 2015 and held it in 5 quarters.
  • First Midwest Bank Trust Division's Sarepta Therapeutics position peaked at $628K in Q2 2016.
  • 186 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2016.

Based on First Midwest Bank Trust Division's 13F filing for Q3 2016, filed 7 Nov 2016.